Skip to content

Moderate Intensity Functional Training as Adjuvant Treatment in Patients With Peripheral Arterial Disease

Vascular-Fit: Efficacy of an In-hospital Physical Exercise Program on Functional Capacity and Quality of Life in Patients With Peripheral Artery Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05126680
Enrollment
15
Registered
2021-11-19
Start date
2021-11-19
Completion date
2023-06-30
Last updated
2024-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermittent Claudication, Peripheral Arterial Disease

Keywords

Peripheral arterial disease, Supervised exercise therapy, Functional training, Intermittent claudication

Brief summary

Traditional aerobic training and muscle resistance ('strength') training have been shown to be effective for improving functional and health-related quality of life (HRQoL) outcomes in peripheral arterial disease (PAD). However, the transfer of the current resistance exercise modes proposed to other activities of daily living (ADLs) is questionable. Moderate intensity functional training (MIFT) has emerged with the aim of achieving cardiovascular and neuromuscular adaptations simultaneously with functional exercises typical of ADLs. The effect of MIFT in patients with PAD is not yet known. Our purpose is to verify the influence of the combination of intermittent treadmill walking exercise with MIFT compared with intermittent treadmill walking exercise on functional capacity, HRQoL, biochemical and hemodynamic parameters in patients with PAD.

Interventions

OTHERSupervised exercise therapy: intermittent treadmill walking exercise and moderate intensity functional training

Subjects will perform a 12-week supervised exercise therapy program based on intermittent treadmill walking exercise (15-30 min.) and moderate intensity functional training (MIFT) (15 min.). In intermittent treadmill walking exercise, the speed and incline of treadmill will be adjusted that patients achieve moderate claudication pain in the time interval between 3 and 5 min. In MIFT, subjects must complete in 15 min. the highest number of repetitions / rounds possible (AMRAP) to a circuit composed of 6 global functional exercises from which they performed 10 repetitions with a rating of perceived exertion (RPE) of 5-7 on a 1 to 10 scale in each exercise.

OTHERSupervised exercise therapy: intermittent treadmill walking exercise

Subjects will perform a 12-week supervised exercise therapy program based on intermittent treadmill walking exercise (30-45 min.). In intermittent treadmill walking exercise, the speed and incline of treadmill will be adjusted that patients achieve moderate claudication pain in the time interval between 3 and 5 min.

Sponsors

Hospital Clínico Universitario de Valladolid
CollaboratorOTHER
European University Miguel de Cervantes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects with PAD in grade IIa (Leriche-Fontaine Classification).

Exclusion criteria

* Subjects with dementia. * Institutionalized Subjects in social health centers. * Subjects with recent major surgery in the last year or lower limb amputations. * Subjects with revascularization surgery of the lower extremities.

Design outcomes

Primary

MeasureTime frameDescription
Six-Minute Walk Test0 weeks, 6 weeks and 12 weeks.Changes in maximum walking distance (MWD) and claudication onset distance (COD).
Moderate intensity functional training Test0 weeks, 6 weeks and 12 weeks.Changes in number of rounds/repetitions and total workload.
Short Form-36 Health Survey (SF-36)0 weeks, 6 weeks and 12 weeks.Changes in the eight domains of health status.
Vascular Quality of Life Questionnaire-6 (VascuQol-6)0 weeks, 6 weeks and 12 weeks.Changes in total punctuation of questionnaire.

Secondary

MeasureTime frameDescription
Biochemical analysis0 weeks, 6 weeks and 12 weeks.Changes in complete lipid profile
Hemodynamic measurements0 weeks, 6 weeks and 12 weeks.Changes in mean, systolic and diastolic blood pressure.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026